Jefferies downgraded Emerson (EMR) to Hold from Buy with an unchanged price target of $145. Emerson has executed on its transformation and already provided its updated outlook, notes the analyst, who sees limited upside in the near-term given the second half guidance ramp.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: